← Open Payments lookup

LISA DABBS: Open Payments

NPI 1689950040 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,110 in 157 payments from 18 companies in 2025. Trend: 2023 $2,784 · 2024 $2,891 · 2025 $3,110

Food & beverage: $3,000Education: $110
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)29$537
Axsome Therapeutics, Inc.25$428
ABBVIE INC.21$425
Teva Pharmaceuticals USA, Inc.10$338
Vanda Pharmaceuticals Inc.14$221
Collegium Pharmaceutical, Inc.12$193
Takeda Pharmaceuticals U.S.A., Inc.10$164
Otsuka America Pharmaceutical, Inc.5$147
Supernus Pharmaceuticals, Inc.6$130
E.R. Squibb & Sons, L.L.C.5$106

Products named: CAPLYTA, Auvelity, VRAYLAR, AUSTEDO XR, FANAPT, REXULTI, Jornay PM, TRINTELLIX.

Industry payments across MS — which companies pay providers there.